ACUTE AND DELAYED-EFFECTS OF DSIP (DELTA-SLEEP-INDUCING PEPTIDE) ON HUMAN SLEEP BEHAVIOR
- 1 January 1981
- journal article
- research article
- Vol. 19 (8), 341-345
Abstract
A 1st study of DSIP (= synthetic delta sleep-inducing peptide) application to humans was carried out in 6 normal volunteers (4 males and 2 females) under extensive psychophysiologic observations and measurements in a double-blind cross-over design. DSIP was applied as slow i.v. infusions at a dosage of 25 nmol/kg in the morning. The subjects immediately reported a feeling of sleep pressure, and sleep increased by 59% (median of total sleep time) within a 130-min interval after the treatment as compared with placebo. Delayed effects on subsequent night sleep were shorter sleep onset, reduced percentage of stage 1 and better sleep efficiency. Nevertheless, sophisticated behavioral and EEG analyses revealed no classic pharmacologic sedation. Evidently, DSIP in humans is also efficacious by sustaining natural sleep functions. The compound was well-tolerated and no psychologic, physiologic or biochemical side effects were observed.This publication has 7 references indexed in Scilit:
- Radioimmunoassay of DSIP-like material in rat brainBrain Research Bulletin, 1978
- Neuropeptides and the blood-brain barrier in goldfishPharmacology Biochemistry and Behavior, 1978
- Effect of the Delta Sleep-Inducing Peptide (DSIP) on the sleep-wakefulness cycle of catsNeuroscience Letters, 1978
- DEGRADATION OF A NONAPEPTIDE, SLEEP INDUCING PEPTIDE, IN RAT-BRAIN - COMPARISON WITH ENKEPHALIN BREAKDOWN1978
- The delta EEG (sleep)-inducing peptide (DSIP)Pflügers Archiv - European Journal of Physiology, 1978
- Degradation of delta sleep inducing peptide (DSIP) and its analogs by brain extractsBrain Research Bulletin, 1977
- Characterization of a delta-electroencephalogram (-sleep)-inducing peptide.Proceedings of the National Academy of Sciences, 1977